For Sun Pharma and DRL, basically the premium that the market was giving them should sustain, says Sonam Udasi of IDBI Capital.

Infosys result was not a big surprise. There was a marginal beat on the consensus so far on the PAT, says Sonam Udasi.

In an interview with ET Now, Sonam Udasi, Head of Research, IDBI Capital, speaks on the RBI data and the RBI Governor’s comments as well as...

Sonam Udasi, Head of Research, IDBI Capital, shares his view on the power sector.

Sonam Udasi, Head of Research, IDBI Capital, shares his view on the telecom sector.

Sonam Udasi, Head of Research, IDBI Capital, shares his view on the pharma sector.

Sonam Udasi, Head of Research, IDBI Capital, shares his view on the Pharma sector.

"Nifty has fallen more than the midcap and small cap because a lot of damage had already happened. Nifty is headed downwards."

"We continue to be overweight on midcap IT and FMCG assuming the second half election will pump priming in the economy."

"So the next one year, you should buy something in media sector. It could be either Zee or it could be Sun TV."

"The Governor assured us to take suitable action as per constitutional provisions", Minister C M Udasi said.

In an interview with ET Now, Sonam Udasi, Head of Research, IDBI Capital, talks about the current market scenario and some sectors and stoc...

"We continue to be very overweight on V-Guard. We have been consistently saying that."

I would rather play an IRB, if I have to play a turnaround story rather than play sugar because it is very volatile. Investors never come t...

In an interview with ET Now, Sonam Udasi, Head of Research, IDBI Capital, talks about the market. Excerpts:

In an interview with ET Now, Sonam Udasi, Head of Research, IDBI Capital, talks about the market and March IIP numbers. Excerpts:

In an interview with ET Now, Sonam Udasi, Head of Research, IDBI Capital, shares his outlook on various stocks. Excerpts: